Physician profile
Keith B Boone
NPI 1265495139
$13,980.94
in general payments reported to CMS, 2019-2025
15 companies · $545 in 2025
The $545 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,077 · 2020: $296 · 2021: $1,178 · 2022: $9,628 · 2023: $709 · 2024: $548 · 2025: $545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,802.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,801.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $7,643.64 | 2021-2023 | |
| Ethicon US, LLC | $2,421.38 | 2019-2025 | Echelon Endopath, Linx Reflux Management System, Echelon Flex |
| Intuitive Surgical, INC. | $1,084.09 | 2019-2023 | Da Vinci Surgical System |
| Karl Storz Endoscopy-America | $830.71 | 2019-2023 | Endoflator |
| Medtronic, INC. | $465.64 | 2023-2025 | Signia, Ligasure, Sonicision |
| Teleflex LLC | $361.59 | 2024-2025 | Titan Sgs Bailout Chuck, Titan Sgs |
| Ethicon INC. | $284.43 | 2021-2022 | |
| Stryker Corporation | $269.65 | 2021-2025 | Spy-Phi System, 1788 |
| Covidien LP | $196.57 | 2019 | |
| Davol INC. | $172.00 | 2022 | |
| Novo Nordisk INC | $138.02 | 2023-2024 | |
| Masimo Corporation | $50.85 | 2021 | |
| Glaxosmithkline, LLC. | $24.11 | 2025 | Ojjaara |
| Boston Scientific Corporation | $20.60 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $17.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Boone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.